PHE COVID-19 vaccination guidance

Syringe with vaccine_AS resized

On 31 December 2019, the World Health Organization (WHO) was informed of a cluster of cases of pneumonia of unknown cause detected in Wuhan City, China. On 12 January 2020, it was announced that a novel coronavirus was identified as the cause of the illnesses being detected. This virus is referred to as SARS-CoV-2, and the associated disease as COVID-19.

On 30 January 2020, the WHO Emergency Committee agreed that the outbreak met the criteria for a Public Health Emergency of International Concern and on 11 March 2020, the WHO declared COVID-19 as a pandemic.

On 02 December 2020, the  UK Department of Health and Social Care and the Medicines and Healthcare products Regulatory Agency authorised the temporary supply of the COVID-19 mRNA Vaccine BNT162b2 (Pfizer-BioNTech), and on 30 December 2020, authorised the temporary supply of the COVID-19 Vaccine AstraZeneca. 

On 08 January 2021, the COVID-19 Vaccine Moderna was given authorisation for temporary supply by the MHRA. It is not currently available in the UK

Please register to continue reading this content

Register for free

Guidelines is completely free for all UK-based healthcare professionals